Benefits
Helps reduce snacking frequency
One 8-week randomized, double-blind, placebo-controlled trial of Satiereal® in 60 mildly overweight women — the only trial of the branded material, conducted with manufacturer (Inoreal) involvement — reported a reduction in snacking frequency between meals versus placebo. It has not been independently replicated. The effect is the most distinctive feature of this saffron extract within the weight-management space.
Supports satiety and reduced grazing
In that same single 60-woman trial, participants self-reported greater satiety and less between-meal grazing on Satiereal®. These are subjective outcomes from one small study, not a separate line of evidence. The ingredient is positioned as a satiety-and-snacking-control adjunct rather than a primary weight-loss intervention.
Modest body weight changes alongside lifestyle support
The single 60-woman Satiereal® trial reported modest reductions in body weight versus placebo over 8 weeks. That is one small, unreplicated brand-specific result — the only other cited trial used generic saffron and crocin in coronary artery disease patients — so it should not be read as a consistent weight-loss finding. Effect sizes are small and best framed as an adjunct to diet and lifestyle support.
May support mood-related eating patterns
Mood research on saffron has used different saffron preparations (such as Affron®) and is not cited on this page, and no mood outcome was measured in the Satiereal® snacking trial. The idea that part of the appetite effect is mediated through mood-related eating patterns such as emotional snacking is a hypothesis about mechanism, not a demonstrated effect of this branded extract.
Mechanism of action
Serotonergic modulation
Crocins and safranal from saffron influence central serotonergic signalling, which is closely tied to satiety and appetite regulation as well as mood. This is the most commonly proposed mechanism for the snacking-control effect seen in the single Satiereal® trial, but it has not been directly measured in people taking this extract.
Dopaminergic / reward pathway modulation
Saffron constituents have been described as modulating dopaminergic signalling in preclinical models, which may dampen reward-driven snacking behavior — particularly relevant for between-meal grazing and emotional eating patterns.
Hypothalamic appetite signalling
Saffron's bioactive carotenoids may interact with central appetite regulators in the hypothalamus, which has been proposed as one explanation for the reduced snacking and higher self-reported satiety seen in the single Satiereal® trial, though this pathway was not measured in that study.
Clinical trials
Randomized, double-blind, placebo-controlled trial of Satiereal® saffron extract (176.5 mg/day) vs placebo in 60 mildly overweight, healthy women over 8 weeks. Outcomes: snacking frequency, subjective satiety, body weight, BMI.
60 mildly overweight healthy women; 8-week intervention.
Satiereal® significantly reduced snacking frequency between meals vs placebo and produced modest reductions in body weight. This is the only trial of the branded material and was conducted with manufacturer (Inoreal) involvement. The small sample (n=60), single-sex healthy population, 8-week duration, and absence of independent replication are key limitations, so it is best read as preliminary support for a snacking-control positioning rather than as a weight-loss result.
8-week randomized, double-blind, placebo-controlled trial of generic saffron aqueous extract and crocin — not Satiereal® — in 84 patients with coronary artery disease. Outcomes: appetite, dietary intake, body composition.
84 coronary artery disease patients; 8-week intervention.
Both saffron extract and crocin reduced appetite and dietary intake vs placebo, with saffron showing greater effects on central obesity measures. Important limitation: this trial tested a generic saffron aqueous extract and crocin — not Satiereal® — in patients with diagnosed coronary artery disease. It is a different material in a disease population, so the results cannot be attributed to Satiereal® or generalized to otherwise healthy adults.